Merck (NYSE:MRK) narrowed its full-year earnings outlook while announcing its second quarter results today. The company revealed that an international cyber attack, which hit the drugmaker in June, halted some of its manufacturing operations. While touting its second quarter financial results, Merck said that it doesn’t yet fully comprehend the magnitude of the disruption caused by the […]
Wall Street Beat
Integer misses expectations on Q2 profits, but grows revenue
Medical device contract manufacturing giant Integer Holdings Co.(NYSE: ITGR) reported a mixed bag when it came to second-quarter results. Nearly two years after Greatbatch and Lake Region Medical merged to create Frisco, Texas–based Integer, sales are growing, but second-quarter profits did not meet analysts’ expectations, according to earnings released yesterday evening. Integer earned $3.0 million, […]
NuVasive shares drop amid mixed Q2 earnings, reorganization efforts
Shares in NuVasive Inc. (NSDQ:NUVA) fell today after the medical device maker posted 2nd quarter earnings that beat earnings per share expectations but fell short on sales with shrinking profits compared to the previous year, alongside announcing a number of changes to its executive roster. The San Diego, Calif.-based company posted profits of $12.7 million, or […]
AtriCure gains on Q2 revenue beat, raised outlook
AtriCure (NSDQ:ATRC) shares gained today after the medical device company yesterday reported higher-than-expected sales and raised its outlook for the rest of the year. The Mason, Ohio-based cardiovascular device company posted losses of -$6.9 million, or -21¢ per share, on sales of $45.2 million for the three months ended June 30, paring its losses by -16.1% […]
Titan Medical closes $7m offering
Titan Medical (TSX:TMD) said today that it closed a stock offering worth about $7 million for the Sport robot-assisted surgery platform it’s developing. The round consisted of two tranches, according to Toronto-based Titan: an initial round worth $5.7 million (C$7.3 million) and a subsequent $1.3 million (C$1.7 million) tranche, for gross proceeds of roughly $7.1 million […]
Tandem shares slide after Q2 sales miss
Shares in Tandem Diabetes Care (NSDQ:TNDM) fell yesterday after the medical device maker missed sales expectations but beat EPS estimates on Wall Street with its second quarter results. The San Diego, Calif.-based company posted a loss of -$21.8 million, or -44¢ per share, on sales of $21.3 million for the 3 months ended June 30, for bottom-line […]
Hill-Rom slips on fiscal Q3 sales miss, lowered outlook
Hill-Rom (NYSE:HRC) shares came under pressure in pre-market trading today after the medical device giant posted fiscal third-quarter results that missed the consensus sales forecast and lowered its outlook for the rest of the year. Chicago-based Hill-Rom reported profits of $6.0 million, or 9¢ per share, on sales of $689.1 million for the three months ended […]
Stryker’s Q2 earnings beat prompts raised outlook
Stryker (NYSE:SYK) yesterday raised its outlook for the rest of the year after reporting second-quarter earnings that beat expectations on Wall Street. The Kalamazoo, Mich.-based medical device company posted profits of $391 million, or $1.03 per share, on sales of $3.01 billion for the three months ended June 30, for a bottom-line gain of 2.9% […]
Boston Scientific warns on fluke S-ICD death
Boston Scientific (NYSE:BSX) last month alerted physicians after learning of a fluke incident involving its S-ICD pacemaker, in which a patient died when the device’s memory was corrupted by radiation. In a June letter to physicians, Marlborough, Mass.-based Boston Scientific wrote of “a single, isolated S-ICD event that resulted in a device-related patient death in May […]
West misses on sales, beats EPS in Q2
Shares in West Pharmaceutical (NYSE:WST) fell today after the manufacturer missed sales estimates on Wall Street with its second quarter results. The Exton, Penn.-based company posted profits of $38.8 million, or 51¢ per share, on sales of $397.6 million for the 3 months ended June 30, for bottom-line loss of -13% on sales growth of 2.5% compared […]
United Therapeutics logs Q2 beat
Shares in United Therapeutics (NSDQ:UTHR) fell today even though the biotech beat expectations on Wall Street with its second quarter results. The company recorded a net loss for the quarter and revealed that it has set aside $210 million for a possible settlement with the Dept. of Justice, according to United’s quarterly regulatory filing. Get the full story […]